BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8622869)

  • 1. The adenovirus E1A-associated 300 kDa adaptor protein counteracts the inhibition of the collagenase promoter by E1A and represses transformation.
    Smits PH; de Wit L; van der Eb AJ; Zantema A
    Oncogene; 1996 Apr; 12(7):1529-35. PubMed ID: 8622869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A.
    Duyndam MC; van Dam H; Smits PH; Verlaan M; van der Eb AJ; Zantema A
    Oncogene; 1999 Apr; 18(14):2311-21. PubMed ID: 10327051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The retinoblastoma gene family members pRB and p107 coactivate the AP-1-dependent mouse tissue factor promoter in fibroblasts.
    Liu SL; Rand A; Kelm RJ; Getz MJ
    Oncogene; 2000 Jul; 19(30):3352-62. PubMed ID: 10918592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators.
    Ghosh AK; Yuan W; Mori Y; Varga J
    Oncogene; 2000 Jul; 19(31):3546-55. PubMed ID: 10918613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human interleukin-5 expression is synergistically regulated by histone acetyltransferase CBP/p300 and transcription factors C/EBP, NF-AT and AP-1.
    Liu C; Lu J; Tan J; Li L; Huang B
    Cytokine; 2004 Aug 21-Sep 7; 27(4-5):93-100. PubMed ID: 15271374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
    Somasundaram K; El-Deiry WS
    Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual action of the adenovirus E1A 243R oncoprotein on the human proliferating cell nuclear antigen promoter: repression of transcriptional activation by p53.
    Kannabiran C; Morris GF; Mathews MB
    Oncogene; 1999 Dec; 18(54):7825-33. PubMed ID: 10618724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of c-Jun-induced mouse major histocompatibility class I promoter (H-2Kb) activity by the Adenovirus type 12-unique 52R E1A protein.
    Brockmann D; Schäfer D; Kirch HC; Esche H
    Oncogene; 1996 Apr; 12(8):1715-25. PubMed ID: 8622892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-specific activation of hTERT-derived promoters by tumor suppressive E1A-mutants involves recruitment of p300/CBP/HAT and suppression of HDAC-1 and defines a combined tumor targeting and suppression system.
    Kirch HC; Ruschen S; Brockmann D; Esche H; Horikawa I; Barrett JC; Opalka B; Hengge UR
    Oncogene; 2002 Nov; 21(52):7991-8000. PubMed ID: 12439749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transactivation of the human cdc2 promoter by adenovirus E1A in cycling cells is mediated by induction of a 110-kDa CCAAT-box-binding factor.
    Tanimoto A; Chen H; Kao CY; Moran E; Sasaguri Y; Padmanabhan R
    Oncogene; 1998 Dec; 17(24):3103-14. PubMed ID: 9872326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcription-repression domain of the adenovirus E1A oncoprotein targets p300 at the promoter.
    Green M; Panesar NK; Loewenstein PM
    Oncogene; 2008 Jul; 27(32):4446-55. PubMed ID: 18408753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53.
    Nevels M; Spruss T; Wolf H; Dobner T
    Oncogene; 1999 Jan; 18(1):9-17. PubMed ID: 9926915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300.
    Vries RG; Prudenziati M; Zwartjes C; Verlaan M; Kalkhoven E; Zantema A
    EMBO J; 2001 Nov; 20(21):6095-103. PubMed ID: 11689449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recruitment of TRRAP required for oncogenic transformation by E1A.
    Deleu L; Shellard S; Alevizopoulos K; Amati B; Land H
    Oncogene; 2001 Dec; 20(57):8270-5. PubMed ID: 11781841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential role for cell cycle control proteins in regulation of the cyclic adenosine 5'-monophosphate-responsive glycoprotein hormone alpha subunit gene.
    Pestell RG; Albanese C; Lee RJ; Watanabe G; Moran E; Johnson J; Jameson JL
    Cell Growth Differ; 1996 Oct; 7(10):1337-44. PubMed ID: 8891337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins.
    Deng Q; Li Y; Tedesco D; Liao R; Fuhrmann G; Sun P
    Cancer Res; 2005 Sep; 65(18):8298-307. PubMed ID: 16166306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co-activator, p300.
    Avantaggiati ML; Carbone M; Graessmann A; Nakatani Y; Howard B; Levine AS
    EMBO J; 1996 May; 15(9):2236-48. PubMed ID: 8641289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cyclin A and decreased cyclin D levels in adenovirus 5 E1A-transformed rodent cell lines.
    Buchou T; Kranenburg O; van Dam H; Roelen D; Zantema A; Hall FL; van der Eb A
    Oncogene; 1993 Jul; 8(7):1765-73. PubMed ID: 8510923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E1A oncogene of adenovirus-12 mediates trans-repression of MHC class I transcription in Ad5/Ad12 somatic hybrid transformed cells.
    Ge R; Liu X; Ricciardi RP
    Virology; 1994 Sep; 203(2):389-92. PubMed ID: 8053163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.